Targeted Therapeutics: CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy (Adv. Biosys. 11/2018).

Breast cancer is a highly heterogenous family of malignant neoplasms with significant interpatient variations. CRISPR technology offers a toolkit to diagnose, model, and treat the disease in a more precise manner. In article number 1800132, Kam W. Leong and co‐workers analyze the potential application of CRISPR technology in these three aspects and provide insights on developing a precision medicine‐based approach against breast cancer. [ABSTRACT FROM AUTHOR]